0001140361-15-019019.txt : 20150512
0001140361-15-019019.hdr.sgml : 20150512
20150512132511
ACCESSION NUMBER: 0001140361-15-019019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150508
FILED AS OF DATE: 20150512
DATE AS OF CHANGE: 20150512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERLIHY WALTER C
CENTRAL INDEX KEY: 0001241029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 15853696
MAIL ADDRESS:
STREET 1: C/O REPLIGEN CORP 41
STREET 2: SEYON ST. BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc1.xml
FORM 4
X0306
4
2015-05-08
0
0000730272
REPLIGEN CORP
RGEN
0001241029
HERLIHY WALTER C
C/O REPLIGEN CORPORATION
41 SEYON ST, BLDG 1, STE 100
WALTHAM
MA
02453
1
1
0
0
PRESIDENT, CEO
Common Stock
2015-05-08
4
S
0
68854
37.55
D
353576
D
Common Stock
2015-05-11
4
S
0
35715
38.6843
D
317861
D
Common Stock
2015-05-11
5
G
0
10000
0
D
307861
D
$37.55 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.90 to $38.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$38.6843 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.22 to $39.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Jeffrey P. Leduc (Attormey in Fact)
2015-05-12